7-8 June 2022: Quality requirements for nanomedicines: what role should the European Pharmacopoeia play?
The aim of this event is to identify any gaps and opportunities for standards concerning modern nanoparticle-based formulations which can be filled by the European Pharmacopoeia (Ph. Eur.), notably by setting common quality standards across Europe and beyond. This has particular relevance in the context of the COVID-19 pandemic.
More info in the EDQM website.
OpenEdition vous propose de citer ce billet de la manière suivante :
egennet (11 mars 2022). 7-8 June 2022: Quality requirements for nanomedicines: what role should the European Pharmacopoeia play? ELSIBI. Consulté le 19 février 2026 à l’adresse https://doi.org/10.58079/o5ua





